PharMEDium Announces Enhanced Agreement with the Child Health Corporation of America (CHCA)

LAKE FOREST, Ill., Nov. 16, 2010 /PRNewswire/ -- David N. Jonas, Chairman and CEO of PharMEDium Healthcare Corporation announced an enhanced agreement with Child Health Corporation of America (CHCA), an Affiliate of Premier, Inc.  Jonas said, "We are excited to work with an organization that shares our core values of providing the highest quality sterile intravenous admixture compounding services, which facilitate the best clinical care and emphasize patient safety first.  As a valued customer, CHCA benefits from the PharMEDium sole source agreement with Premier for admixtures and compounding services."

Ben Lizak, Manager, Pharmacy Contracting for CHCA, commented, "Currently, there are thirteen (13) CHCA Owner Hospitals utilizing PharMEDium for Outsourced Pharmacy Compounding Services.  Now, all 34 Owner Hospitals that participate in CHCA's Group Purchasing Services program can benefit from even more savings on hundreds of sterile IV admixtures that they can obtain quickly and conveniently from a trusted Premier business partner."

Child Health Corporation of America (CHCA) children's hospitals represent more than 20,000 physicians, 135,000 employees, $25 billion in revenue and $2.1 billion in overall medical, surgical and pharmaceutical products. CHCA is headquartered in Shawnee Mission, Kansas.  Jennifer Adams, Vice President, Sales, for PharMEDium, stated, "We are honored to be affiliated with CHCA Owner Hospitals who are North America's leading children's hospitals and widely known for their excellence in caring for America's children."

PharMEDium is the national leading provider of pharmacy sterile intravenous admixture compounding services. The PharMEDium network of state licensed and federally registered compounding centers provides trusted solutions to hospitals throughout the United States. PharMEDium complies with all applicable state laws and FDA regulations, including USP Chapter (797), and DEA requirements.  For more information on PharMEDium, visit www.pharmedium.com.

SOURCE PharMEDium